Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Calcineurin Inhibitor Withdrawal or Tapering for Kidney Transplant Recipients." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305202/all/Calcineurin_inhibitor_withdrawal_or_tapering_for_kidney_transplant_recipients.
Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305202/all/Calcineurin_inhibitor_withdrawal_or_tapering_for_kidney_transplant_recipients. Accessed November 4, 2024.
Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305202/all/Calcineurin_inhibitor_withdrawal_or_tapering_for_kidney_transplant_recipients
Calcineurin Inhibitor Withdrawal or Tapering for Kidney Transplant Recipients [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 November 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305202/all/Calcineurin_inhibitor_withdrawal_or_tapering_for_kidney_transplant_recipients.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients
ID - 1305202
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305202/all/Calcineurin_inhibitor_withdrawal_or_tapering_for_kidney_transplant_recipients
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -